Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach.

Experimental study in rats investigating unilateral adrenalectomy and BPC 157 therapy

“This rat study reveals a new point: the considerable impact of unilateral adrenalectomy, severe vascular and multiorgan failure, occlusion/occlusion-like syndrome, and the stable gastric pentadecapeptide BPC 157 therapy.”

Rats subjected to unilateral adrenalectomy

“In rats, unilateral adrenalectomy (at 15 min, 5 h, 24 h) leads to integrated gross and morphological changes, vascular alterations, oxidative stress parameters, molecular markers and occlusion/occlusion-like syndrome and BPC 157 as useful therapy (/kg ig) (10 µg, 10 ng).”

6 rats per group

“Summary of statistical comparisons across systemic, organ-specific, functional, morphometric, and molecular endpoints (n = 6 per group).”

Assessments conducted at 15 minutes, 5 hours, and 24 hours post-surgery

“In rats, unilateral adrenalectomy (at 15 min, 5 h, 24 h) leads to integrated gross and morphological changes, vascular alterations, oxidative stress parameters, molecular markers and occlusion/occlusion-like syndrome and BPC 157 as useful therapy (/kg ig) (10 µg, 10 ng).”

BPC 157 therapy attenuated or eliminated intracranial, portal, and caval hypertension, as well as aortic hypotension

“Attenuated/eliminated were arrhythmias, intracranial (superior sagittal sinus), portal, caval hypertension, and aortic hypotension.”

BPC 157 therapy counteracted thrombosis and lesions in multiple organs including the brain, heart, lung, liver, kidney, and gastrointestinal tract

“Peripherally and centrally, counteraction includes the lesions (adrenal, brain, heart, lung, liver, kidney, gastrointestinal tract), organ hemorrhage, and thrombosis.”

BPC 157 therapy increased NO levels, counteracted oxidative stress (MDA), and upregulated NOS1–3 and VEGF-A expression

“For the indicative conclusion along with previous studies, mechanistically, BPC 157 therapy exhibits the NO-system modulation/oxidative stress balance, increases NO-level, counteracts oxidative stress (malondialdehyde (MDA)), upregulates NOS1–3, and VEGF-A expression.”

The breadth of parameters assessed may be a weakness regarding the particularities of assessment for each parameter

“Notably, this very breadth may also become a weakness in the current report.”